Capsida Biotherapeutics is focused on developing innovative gene therapies using its proprietary AAV (adeno-associated virus) platform to treat various diseases
Capsida Biotherapeutics is focused on developing innovative gene therapies using its proprietary AAV (adeno-associated virus) platform to treat various diseases.
The top three firms on F4's Biotech & Life Sciences investor list.